Optimal Timing for Interim Analyses in Clinical Trials

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.23, Iss.5, 2013-09, pp. : 1067-1080

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interim Analyses in Clinical Trials

Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. : 113-116

Karger

Access to resources Recommend Favorite

Strategies for Including Patients Recruited During Interim Analysis of Clinical Trials

By Faldum Andreas Hommel Gerhard

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1211-1225

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Allocation of Sample Sizes to Multicenter Clinical Trials

By Lai Dejian Chang Kuang-Chao Rahbar Mohammad H. Moye Lemuel A.

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 4, 2013-07 ,pp. : 818-828

Taylor & Francis Ltd

Access to resources Recommend Favorite

Subgroup Analyses in Randomized Clinical Trials: Statistical and Regulatory Issues

By Grouin Jean-Marie

Journal of Biopharmaceutical Statistics, Vol. 15, Iss. 5, 2005-01 ,pp. : 869-882

Taylor & Francis Ltd

Access to resources Recommend Favorite

Mobilizing pharmacogenomic analyses during clinical trials in drug development

By Bienfait Karina L Shaw Peter M Murthy Gowri Warner Amelia Wall

Pharmacogenomics, Vol. 14, Iss. 10, 2013-07 ,pp. : 1227-1235

Future Medicine

Access to resources Recommend Favorite